| The Medicine Chest | |
| 99 Maple St, Ste 21, Middlebury, Vermont 05753 | |
| (802) 388-9801 |
| Name | The Medicine Chest |
|---|---|
| Organization Name | Smith Management Services Llc |
| Location | 99 Maple St, Ste 21, Middlebury, Vermont 05753 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (802) 388-9801 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Shield Therapeutics, the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has successfully raised EUR8.2m from Inventages Venture Capital (Inventages) in its first institutional financing round.
If some regions become hot spots and hospitals reach maximum capacity during the COVID-19 pandemic, hospitals have plans for how to decide who gets critical care resources, such as a bed in the intensive care unit or a respirator.
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has exercised its option to purchase $12.8 million of additional convertible preferred stock under the terms described in the financing agreements approved by GTC shareholders in July 2009. This transaction provides $6.4 million of new cash proceeds to GTC.
› Verified 4 days ago
| NPI Number | 1154380178 |
| Organization Name | PHARMACY HEALTH SERVICES, INC |
| Doing Business As | THE MEDICINE CHEST |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 99 Maple St, Suite 21, Middlebury, VT 05753 |
| Phone Number | 802-388-9801 |
News Archive
Shield Therapeutics, the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has successfully raised EUR8.2m from Inventages Venture Capital (Inventages) in its first institutional financing round.
If some regions become hot spots and hospitals reach maximum capacity during the COVID-19 pandemic, hospitals have plans for how to decide who gets critical care resources, such as a bed in the intensive care unit or a respirator.
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has exercised its option to purchase $12.8 million of additional convertible preferred stock under the terms described in the financing agreements approved by GTC shareholders in July 2009. This transaction provides $6.4 million of new cash proceeds to GTC.
› Verified 4 days ago
| NPI Number | 1235675182 |
| Organization Name | SMITH MANAGEMENT SERVICES LLC |
| Doing Business As | MARBLE WORKS PHARMACY |
| Type | Community/Retail Pharmacy |
| Address | 99 Maple St, Middlebury, VT 05753 |
| Phone Number | 802-388-3784 |
News Archive
Shield Therapeutics, the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has successfully raised EUR8.2m from Inventages Venture Capital (Inventages) in its first institutional financing round.
If some regions become hot spots and hospitals reach maximum capacity during the COVID-19 pandemic, hospitals have plans for how to decide who gets critical care resources, such as a bed in the intensive care unit or a respirator.
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has exercised its option to purchase $12.8 million of additional convertible preferred stock under the terms described in the financing agreements approved by GTC shareholders in July 2009. This transaction provides $6.4 million of new cash proceeds to GTC.
› Verified 4 days ago
| NPI Number | 1538605910 |
| Organization Name | SMITH MANAGEMENT SERVICES LLC |
| Doing Business As | THE MEDICINE CHEST |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Address | 99 Maple St, Middlebury, VT 05753 |
| Phone Number | 802-388-9801 |
News Archive
Shield Therapeutics, the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has successfully raised EUR8.2m from Inventages Venture Capital (Inventages) in its first institutional financing round.
If some regions become hot spots and hospitals reach maximum capacity during the COVID-19 pandemic, hospitals have plans for how to decide who gets critical care resources, such as a bed in the intensive care unit or a respirator.
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has exercised its option to purchase $12.8 million of additional convertible preferred stock under the terms described in the financing agreements approved by GTC shareholders in July 2009. This transaction provides $6.4 million of new cash proceeds to GTC.
› Verified 4 days ago
| NPI Number | 1871191171 |
| Organization Name | THE MEDICINE CHEST, LLC |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Address | 99 Maple St Ste 21, Middlebury, VT 05753 |
| Phone Number | 802-388-9801 |
News Archive
Shield Therapeutics, the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has successfully raised EUR8.2m from Inventages Venture Capital (Inventages) in its first institutional financing round.
If some regions become hot spots and hospitals reach maximum capacity during the COVID-19 pandemic, hospitals have plans for how to decide who gets critical care resources, such as a bed in the intensive care unit or a respirator.
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has exercised its option to purchase $12.8 million of additional convertible preferred stock under the terms described in the financing agreements approved by GTC shareholders in July 2009. This transaction provides $6.4 million of new cash proceeds to GTC.
› Verified 4 days ago
News Archive
Shield Therapeutics, the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has successfully raised EUR8.2m from Inventages Venture Capital (Inventages) in its first institutional financing round.
If some regions become hot spots and hospitals reach maximum capacity during the COVID-19 pandemic, hospitals have plans for how to decide who gets critical care resources, such as a bed in the intensive care unit or a respirator.
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has exercised its option to purchase $12.8 million of additional convertible preferred stock under the terms described in the financing agreements approved by GTC shareholders in July 2009. This transaction provides $6.4 million of new cash proceeds to GTC.
› Verified 4 days ago
Hannaford Food & Drug #8121 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 260 Court St, Middlebury, Vermont 05753 Phone: (802) 388-6349 | |
Walgreens#18375 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 263 Court St, Middlebury, Vermont 05753 Phone: (802) 388-9573 | |
The Medicine Chest Type: Durable Medical Equipment & Medical Supplies Supplier Location: 99 Maple St, Middlebury, Vermont 05753 Phone: (802) 388-9801 | |
Vermont Medical Sleep Disorders Cen Type: Durable Medical Equipment & Medical Supplies Supplier Location: 812 Exchange St 6, Middlebury, Vermont 05753 Phone: (802) 382-8880 |